News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Klein Lawrence Otto
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Klein Lawrence Otto (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
| 10/13/2022 |
4
| Klein Lawrence Otto (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 24,500 shares
@ $0 |
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2021 |
4
| Klein Lawrence Otto (CBO & COO) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 13,800 options to buy
@ $97, valued at
$1.3M
|
|
| 10/01/2021 |
3
| Klein Lawrence Otto (Director) has filed a Form 3 on Jasper Therapeutics, Inc. |
| 09/14/2021 |
4
| Klein Lawrence Otto (CBO & COO) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Exercised 10,000 shares
@ $0
Paid exercise price by delivering 4,207 shares
@ $117.86, valued at
$495.8k
Paid exercise price by delivering 10,000 restricted stock units
@ $0 |
|
| 05/27/2021 |
4
| Klein Lawrence Otto (Director) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 19,596 options to buy
@ $19.56, valued at
$383.3k
|
|
| 03/25/2021 |
4
| Klein Lawrence Otto (CBO & COO) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 88,000 shares
@ $128.2, valued at
$11.3M
Sold 12,000 shares
@ $126.97, valued at
$1.5M
Exercised 12,000 options to buy
@ $14.43, valued at
$173.2k
Exercised 12,000 options to buy
@ $17.66, valued at
$211.9k
Exercised 22,000 options to buy
@ $51.49, valued at
$1.1M
Exercised 10,000 options to buy
@ $29.87, valued at
$298.7k
Exercised 20,000 options to buy
@ $40.87, valued at
$817.4k
Exercised 12,000 options to buy
@ $44.67, valued at
$536k
|
|
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2020 |
4
| Klein Lawrence Otto (CBO & COO) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 16,666 options to buy
@ $86.75, valued at
$1.4M
|
|
| 09/23/2020 |
4
| Klein Lawrence Otto (Director) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Converted 10,725 shares
@ $0
Granted 11,156 options to buy
@ $5.54, valued at
$61.8k
Granted 14,444 options to buy
@ $5.54, valued at
$80k
Bought 35,574 preferred shares
@ $2.811, valued at
$100k
Converted 35,574 preferred shares
@ $0 |
|
| 09/16/2020 |
3
| Klein Lawrence Otto (Director) has filed a Form 3 on Dyne Therapeutics, Inc. |
| 06/26/2020 |
4
| Klein Lawrence Otto (CBO & COO) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 15,966 shares
@ $75.9279, valued at
$1.2M
Sold 22,700 shares
@ $76.5011, valued at
$1.7M
Sold 6,600 shares
@ $74.8974, valued at
$494.3k
Sold 3,934 shares
@ $75.937, valued at
$298.7k
Sold 800 shares
@ $76.5012, valued at
$61.2k
Sold 12,175 shares
@ $75.3227, valued at
$917.1k
Sold 2,913 shares
@ $76.2575, valued at
$222.1k
Sold 4,912 shares
@ $75.1776, valued at
$369.3k
Exercised 38,666 options to buy
@ $5.86, valued at
$226.6k
Exercised 26,422 options to buy
@ $12.57, valued at
$332.1k
Exercised 4,912 options to buy
@ $12.57, valued at
$61.7k
|
|
| 05/13/2020 |
4
| Klein Lawrence Otto (CBO & COO) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 24,318 shares
@ $60.38, valued at
$1.5M
Sold 682 shares
@ $61.07, valued at
$41.6k
Exercised 25,000 options to buy
@ $5.86, valued at
$146.5k
|
|
| 03/12/2020 |
4
| Klein Lawrence Otto (CBO & COO) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 55,000 options to buy
@ $44.67, valued at
$2.5M
Granted 13,750 restricted stock units
@ $0 |
|
| 12/05/2019 |
4
| Klein Lawrence Otto (Chief Business Officer) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 40,000 restricted stock units
@ $0 |
|
| 09/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2019 |
4
| Klein Lawrence Otto (Chief Business Officer) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 11,579 shares
@ $50.02, valued at
$579.2k
Sold 8,421 shares
@ $50.0144, valued at
$421.2k
Exercised 11,579 options to buy
@ $5.86, valued at
$67.9k
Exercised 8,421 options to buy
@ $5.86, valued at
$49.3k
|
|
| 03/07/2019 |
4
| Klein Lawrence Otto (Chief Business Officer) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 45,000 options to buy
@ $40.87, valued at
$1.8M
|
|
| 01/03/2019 |
4
| Klein Lawrence Otto (Chief Business Officer) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 20,000 shares
@ $29.87, valued at
$597.4k
Granted 20,000 options to buy
@ $29.87, valued at
$597.4k
|
|
| 01/03/2019 |
3
| Klein Lawrence Otto (Chief Business Officer) has filed a Form 3 on CRISPR Therapeutics AG |
|
|